ezetimibe

Generic: ezetimibe

Labeler: orient pharma co., ltd.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ezetimibe
Generic Name ezetimibe
Labeler orient pharma co., ltd.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ezetimibe 10 mg/1

Manufacturer
Orient Pharma Co., Ltd.

Identifiers & Regulatory

Product NDC 76333-170
Product ID 76333-170_161b88d8-6679-e793-e063-6394a90a481b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215693
Listing Expiration 2026-12-31
Marketing Start 2022-06-30

Pharmacologic Class

Established (EPC)
dietary cholesterol absorption inhibitor [epc]
Physiologic Effect
decreased cholesterol absorption [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76333170
Hyphenated Format 76333-170

Supplemental Identifiers

RxCUI
349556
UNII
EOR26LQQ24
NUI
N0000008553 N0000175911

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ezetimibe (source: ndc)
Generic Name ezetimibe (source: ndc)
Application Number ANDA215693 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (76333-170-12)
  • 500 TABLET in 1 BOTTLE (76333-170-13)
  • 90 TABLET in 1 BOTTLE (76333-170-14)
  • 30 TABLET in 1 BOTTLE (76333-170-15)
source: ndc

Packages (4)

Ingredients (1)

ezetimibe (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "161b88d8-6679-e793-e063-6394a90a481b", "openfda": {"nui": ["N0000008553", "N0000175911"], "unii": ["EOR26LQQ24"], "rxcui": ["349556"], "spl_set_id": ["b6e77d9b-a553-63e0-e053-2a95a90a18fe"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "pharm_class_epc": ["Dietary Cholesterol Absorption Inhibitor [EPC]"], "manufacturer_name": ["Orient Pharma Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76333-170-12)", "package_ndc": "76333-170-12", "marketing_start_date": "20231113"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (76333-170-13)", "package_ndc": "76333-170-13", "marketing_start_date": "20231113"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76333-170-14)", "package_ndc": "76333-170-14", "marketing_start_date": "20231113"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76333-170-15)", "package_ndc": "76333-170-15", "marketing_start_date": "20220630"}], "brand_name": "Ezetimibe", "product_id": "76333-170_161b88d8-6679-e793-e063-6394a90a481b", "dosage_form": "TABLET", "pharm_class": ["Decreased Cholesterol Absorption [PE]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "product_ndc": "76333-170", "generic_name": "Ezetimibe", "labeler_name": "Orient Pharma Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ezetimibe", "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}], "application_number": "ANDA215693", "marketing_category": "ANDA", "marketing_start_date": "20220630", "listing_expiration_date": "20261231"}